03:52:11 | ◀︎ | VIDEO: Extinct Tasmanian tiger's weak jaws | |
03:57:44 | ◀︎ | Fabled killer beast had weak jaws | |
06:15:32 | ◀︎ | Tomb found at Stonehenge quarry | |
10:18:19 | ◀︎ | Stem cell stroke trial 'is safe' | |
10:19:27 | ◀︎ | Tokyo roads shut in quake drill | |
10:30:33 | ◀︎ | Jersey's Neanderthal survival story | |
10:30:33 | ◀︎ | Meteor hunt for Irish stargazers | |
10:30:33 | ◀︎ | 'Anti-cancer virus' shows promise | |
11:05:08 | ◀︎ | Major dig under way at hill fort | |
12:48:40 | ◀︎ | Deer 'pill' curbs aggressive mating | |
14:34:39 | ◀︎ | Apple defends record on pollution | |
14:34:39 | ◀︎ | Hologram microscope spots E. coli | |
15:07:02 | ◀︎ | Higgs could be found by Christmas | |
16:11:20 | ◀︎ | Museums wage war on hungry bugs | |
23:42:17 | ◀︎ | Exciting stone tool find in Kenya |
זמני השבת
עיר | כניסה | יציאה |
---|---|---|
ירושלים | 18:03 | 19:13 |
תל אביב | 18:17 | 19:15 |
חיפה | 18:09 | 19:15 |
באר שבע | 18:20 | 19:16 |
הכותרות שעניינו הכי הרבה גולשים בדף זה
01/09/11 03:52
0% מהצפיות
מאת BBC News
The extinct Tasmanian tiger has been revealed to have had jaws too weak to threaten livestock
01/09/11 03:57
0% מהצפיות
מאת BBC News
The extinct Tasmanian tiger, hunted because it was thought to kill livestock, was "too weak" to prey on sheep, say scientists.
01/09/11 06:15
0% מהצפיות
מאת BBC News
Those responsible for erecting Stonehenge could have been unearthed by an excavation at the site where the original bluestones were quarried in 2300BC.
01/09/11 10:18
0% מהצפיות
מאת BBC News
The world's first clinical trial of stem cells to treat strokes is set to move to its next phase.
01/09/11 10:19
0% מהצפיות
מאת BBC News
Japanese police block main roads in Tokyo during rush hour to simulate gridlock in an elaborate annual earthquake drill.
01/09/11 10:30
0% מהצפיות
מאת BBC News
Have we underestimated the Neanderthals?
01/09/11 10:30
0% מהצפיות
מאת BBC News
Stargazers across Ireland are on the hunt for a meteor that could have landed earlier this month.
01/09/11 10:30
0% מהצפיות
מאת BBC News
A virus has been engineered to selectively target cancer cells, which researchers say could one day "truly transform" therapies.